showed that a mitochondrial isoform of glutaminase, GLS2, was associated with radioresistance in cervical cancer and its inhibition led to increased radiosensitivity, suggesting that the inhibition of GLS2 may be a potential treatment strategy for radioresistant cervical cancer [105]. Here, GLS2 is linked to cervical carcinoma.